Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis
Caglayan Selenge Beduk Esen, Sukran Celikarslan, Duygu Sezen, Fatih Selcukbiricik, Kerim Kaban, Metin Kanitez, Perran Fulden Yumuk, Nil Molinas Mandel, Levent Tabak, Ezgi Cesur, Suat Erus, Serhan Tanju, Sukru Dilege, Terman Gumus, Cetin Atasoy, Cengiz Demirkurek, Okan Falay, Mehmet Onur Demirkol, Pinar Bulutay, Pinar Firat, Melis Selek, Merve Duman, Sepideh Mohammadipour, Saliha Ezgi Oymak, Nulifer Kilic Durankus, Yasemin Atagun, Ugur Selek · 2026
Read Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis by Caglayan Selenge Beduk Esen, Sukran Celikarslan, Duygu Sezen, Fatih Selcukbiricik, Kerim Kaban, Metin Kanitez, Perran Fulden Yumuk, Nil Molinas Mandel, Levent Tabak, Ezgi Cesur, Suat Erus, Serhan Tanju, Sukru Dilege, Terman Gumus, Cetin Atasoy, Cengiz Demirkurek, Okan Falay, Mehmet Onur Demirkol, Pinar Bulutay, Pinar Firat, Melis Selek, Merve Duman, Sepideh Mohammadipour, Saliha Ezgi Oymak, Nulifer Kilic Durankus, Yasemin Atagun, Ugur Selek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13360162.txt.
Description
Caglayan Selenge Beduk Esen led a 2026 real-world study of lung cancer that cannot be removed by surgery. The patients had non-small cell lung cancer that had spread within the chest but not beyond it. Their care began with chemo plus immune drugs. Radiation to the chest in strong, focused doses followed.
The team found that this order of care kept the cancer in check in the chest and gave hopeful survival results. Side effects stayed within a range the doctors found acceptable. Care like this takes place outside strict trial rules, so the results show how the plan works in daily practice. The authors say the approach deserves testing in planned trials with set rules.
Catalog record
| CREATOR | Caglayan Selenge Beduk Esen, Sukran Celikarslan, Duygu Sezen, Fatih Selcukbiricik, Kerim Kaban, Metin Kanitez, Perran Fulden Yumuk, Nil Molinas Mandel, Levent Tabak, Ezgi Cesur, Suat Erus, Serhan Tanju, Sukru Dilege, Terman Gumus, Cetin Atasoy, Cengiz Demirkurek, Okan Falay, Mehmet Onur Demirkol, Pinar Bulutay, Pinar Firat, Melis Selek, Merve Duman, Sepideh Mohammadipour, Saliha Ezgi Oymak, Nulifer Kilic Durankus, Yasemin Atagun, Ugur Selek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28857 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |